These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3100367)

  • 1. No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy.
    Pietschmann P; Schernthaner G; Prskavec F; Gisinger C; Freyler H
    Diabetes; 1987 Feb; 36(2):159-62. PubMed ID: 3100367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus.
    Krassowski J; Felber JP; Rogala H; Jeske W; Zgliczynski S
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):225-9. PubMed ID: 3132790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone responses to growth-hormone-releasing hormone and thyrotropin-releasing hormone in diabetic patients with and without retinopathy.
    Kaneko K; Komine S; Maeda T; Ohta M; Tsushima T; Shizume K
    Diabetes; 1985 Jul; 34(7):710-3. PubMed ID: 3924695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of growth hormone control in diabetes.
    Hyer SL; Kohner EM
    Aust N Z J Ophthalmol; 1990 Feb; 18(1):33-9. PubMed ID: 2113400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-stimulated growth hormone secretion and diabetic retinopathy.
    Holland PM; Landers MB; Lebovitz HE; Wolbarsht ML
    Am J Ophthalmol; 1976 Oct; 82(4):612-8. PubMed ID: 970425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects.
    Coiro V; Volpi R; Capretti L; Speroni G; Caffarri G; Marchesi C; Chiodera P
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):487-95. PubMed ID: 10583317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is growth hormone associated with diabetic retinopathy?
    Hattori N; Moridera K; Ishihara T; Hino M; Ikekubo K; Kurahachi H
    J Diabetes Complications; 1993; 7(1):12-4. PubMed ID: 8481545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and clinical applications of measurement of urinary growth hormone in diabetic subjects.
    Suzuki K; Miyata H; Suzuki T; Kajinuma H
    Diabetes; 1989 Dec; 38(12):1567-72. PubMed ID: 2684712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth hormone response to arginine administration in diabetics--with special reference to the multiple regression analysis in association with diabetic retinopathy].
    Kitada M; Yasuda K; Takeda N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):558-71. PubMed ID: 2792459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF(1-44)] in type 2 (non-insulin-dependent) diabetes.
    Richards NT; Wood SM; Christofides ND; Bhuttacharji SC; Bloom SR
    Diabetologia; 1984 Nov; 27(5):529-34. PubMed ID: 6439589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of growth hormone in the development of diabetic retinopathy.
    Alzaid AA; Dinneen SF; Melton LJ; Rizza RA
    Diabetes Care; 1994 Jun; 17(6):531-4. PubMed ID: 8082520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus.
    Caviezel F; Lepore G; Maglio ML; Croci M; Comi G; Morricone L
    Acta Diabetol Lat; 1989; 26(2):133-45. PubMed ID: 2781979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone releasing hormone on growth hormone secretion in type 2 (non-insulin-dependent) diabetes mellitus.
    Pietschmann P; Schernthaner G
    Diabetologia; 1987 Jan; 30(1):13-5. PubMed ID: 3106123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging.
    Iovino M; Monteleone P; Steardo L
    J Clin Endocrinol Metab; 1989 Oct; 69(4):910-3. PubMed ID: 2506218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
    de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
    Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):344-8. PubMed ID: 1345575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum growth hormone (GH) and the responses to thyrotropin-releasing hormone (TRH) in diabetes mellitus: lack of evidence for TRH evoked GH secretion.
    Small M; Cohen HN; MacLean JA; Beastall GH; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):89-94. PubMed ID: 6442227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Wesemeyer G; Döhler KD; Sandow J
    Endocrinology; 1987 Feb; 120(2):732-8. PubMed ID: 2879724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.